Grifols, S.A. Overview
Company Headquarters: Barcelona, Spain
Founded: 1940
Workforce: 24,003
Company Working: Grifols, S.A. is a global leader in producing plasma-derived medicines and transfusion medicine. It operates through major four business segments namely, bioscience, diagnostic, hospital, and bio supplies. The bioscience division offers plasma medicines for the treatment of chronic, rare, and other life-threatening conditions. It has three manufacturing facilities for plasma-derived medicines one is located in Spain and the other two located in the US. The diagnostic division offers diagnostic solutions for disease detection and management of laboratory operations. Hospital division offers equipment, software, and services used in for operational pharmacy. The bio supplies business segment offers biological products for non-therapeutic areas. The company offers its broad range of products and services in more than 100 countries. It has a strong presence in North America and Europe.
Strategy
Grifols, S.A. has an extensive product portfolio due to its strong infrastructure in R&D. Moreover, the company aims to develop high-quality, high-impact solutions by increasing its R&D investment in the near future. Also, it is actively involved in developing training programs in the pharmaceutical industry to gain the attention of its potential customers.
